Basilea Pharmaceutica AG
BPMUF
$54.00
$1.172.22%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 32.37M | 32.87M | 11.47M | 11.86M | -12.08M |
| Total Depreciation and Amortization | 1.43M | 1.45M | 402.00K | 415.70K | 1.43M |
| Total Amortization of Deferred Charges | 244.80K | 248.60K | 259.90K | 268.80K | 561.30K |
| Total Other Non-Cash Items | -1.98M | -2.01M | -5.63M | -5.82M | 605.90K |
| Change in Net Operating Assets | 75.20K | 76.30K | 3.41M | 3.52M | 5.18M |
| Cash from Operations | 32.14M | 32.63M | 9.91M | 10.25M | -4.30M |
| Capital Expenditure | -707.70K | -718.50K | -258.20K | -267.10K | -281.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 0.00 | 0.00 | 431.80K | 446.60K | -- |
| Other Investing Activities | -16.50K | -16.80K | -29.30K | -30.30K | -82.40K |
| Cash from Investing | -724.20K | -735.30K | 144.30K | 149.30K | -364.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | -7.80M | -7.80M | -20.44M |
| Issuance of Common Stock | 73.50K | 73.50K | 1.16M | 1.16M | 523.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -84.50K | -84.50K | 74.00K | 74.00K | -192.00K |
| Cash from Financing | -12.50K | -12.70K | -7.27M | -7.52M | -22.71M |
| Foreign Exchange rate Adjustments | -33.60K | -34.10K | 60.30K | 62.30K | -78.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -600.00 |
| Net Change in Cash | 31.37M | 31.85M | 2.85M | 2.94M | -27.46M |
